Non-alcoholic fatty liver disease (NAFLD) is a public health problem worldwide. This
narrative Review provides an overview of the current literature to support the notion that …

Nonalcoholic fatty liver disease (NAFLD) is a major public health crisis affecting
approximately 25% of the world's population. The spectrum of NAFLD ranges from bland …

Objective We performed a meta-analysis of observational studies to quantify the magnitude
of the association between non-alcoholic fatty liver disease (NAFLD) and risk of extrahepatic …

Abstract Aims Triglyceride–glucose (TyG) index has been proposed as a simple surrogate
marker of insulin resistance. However, few studies have investigated the association of TyG …

Background Metabolic dysfunction-associated fatty liver disease (MAFLD) is a significant
health issue closely associated with multiple metabolic dysfunctions. The association …

Abstract Background and Aims Individuals with non‐alcoholic fatty liver disease (NAFLD)
may be at greater risk of cancer. This study aimed to investigate the risk of hepatic and …

Colorectal adenoma is linked to metabolic dysfunction. Metabolic dysfunction-associated
fatty liver disease (MAFLD) has a precise definition and three subtypes, including non-obese …

Epidemiologic evidence on metal mixtures and non-alcoholic fatty liver disease (NAFLD) is
limited. We aimed to assess the relationship between multiple metal co-exposure and …

Metabolic (dysfunction)-associated fatty liver disease (MAFLD) is currently the most common
chronic liver disease and affects at least a quarter of the global adult population. It has …

Abstract Background and Aims The evidence of the relationship between dietary
approaches to stop hypertension (DASH) and non‐alcoholic fatty liver disease (NAFLD) is …